Biogen Idec Inc. Presentation Networks

Line Image Concept Label Concept Type Period type Balance Concept name
* Network: (00 - Document - Document and Company Information)
1 biib: Document And Company Information [Abstract] xbrli:stringItemType duration biib:DocumentAndCompanyInformationAbstract
2 dei: Entity Registrant Name xbrli:normalizedStringItemType duration dei:EntityRegistrantName
3 dei: Entity Central Index Key us-types:centralIndexKeyItemType duration dei:EntityCentralIndexKey
4 dei: Document Type us-types:SECReportItemType duration dei:DocumentType
5 dei: Document Period End Date xbrli:dateItemType duration dei:DocumentPeriodEndDate
6 dei: Amendment Flag xbrli:booleanItemType duration dei:AmendmentFlag
7 dei: Current Fiscal Year End Date xbrli:gMonthDayItemType duration dei:CurrentFiscalYearEndDate
8 dei: Entity Well-known Seasoned Issuer us-types:yesNoItemType duration dei:EntityWellKnownSeasonedIssuer
9 dei: Entity Voluntary Filers us-types:yesNoItemType duration dei:EntityVoluntaryFilers
10 dei: Entity Current Reporting Status us-types:yesNoItemType duration dei:EntityCurrentReportingStatus
11 dei: Entity Filer Category us-types:filerCategoryItemType duration dei:EntityFilerCategory
12 dei: Entity Public Float xbrli:monetaryItemType instant credit dei:EntityPublicFloat
13 dei: Entity Common Stock, Shares Outstanding xbrli:sharesItemType instant dei:EntityCommonStockSharesOutstanding
* Network: (01 - Statement - Consolidated Statements of Income (Unaudited))
14 us-gaap: Statement of Income [Abstract] xbrli:stringItemType duration us-gaap:IncomeStatementAbstract
15 us-gaap: Statement [Table] xbrli:stringItemType duration us-gaap:StatementTable
16 us-gaap: Statement [Line Items] xbrli:stringItemType duration us-gaap:StatementLineItems
17 us-gaap: Revenues: xbrli:stringItemType duration us-gaap:RevenuesAbstract
18 us-gaap: Product xbrli:monetaryItemType duration credit us-gaap:SalesRevenueGoodsNet
19 biib: Unconsolidated joint business xbrli:monetaryItemType duration credit biib:UnconsolidatedJointBusiness
20 us-gaap: Other revenues xbrli:monetaryItemType duration credit us-gaap:OtherSalesRevenueNet
21 us-gaap: Total revenues xbrli:monetaryItemType duration credit us-gaap:Revenues
22 us-gaap: Costs and expenses: xbrli:stringItemType duration us-gaap:CostsAndExpensesAbstract
23 us-gaap: Cost of sales, excluding amortization of acquired intangible assets xbrli:monetaryItemType duration debit us-gaap:CostOfRevenue
24 us-gaap: Research and development xbrli:monetaryItemType duration debit us-gaap:ResearchAndDevelopmentExpense
25 us-gaap: Selling, general and administrative xbrli:monetaryItemType duration debit us-gaap:SellingGeneralAndAdministrativeExpense
26 biib: Collaboration profit sharing xbrli:monetaryItemType duration debit biib:CollaborationProfitSharing
27 us-gaap: Amortization of acquired intangible assets xbrli:monetaryItemType duration debit us-gaap:AmortizationOfIntangibleAssets
28 us-gaap: Acquired in-process research and development xbrli:monetaryItemType duration debit us-gaap:ResearchAndDevelopmentInProcess
29 us-gaap: Total costs and expenses xbrli:monetaryItemType duration debit us-gaap:CostsAndExpenses
30 us-gaap: Income from operations xbrli:monetaryItemType duration credit us-gaap:OperatingIncomeLoss
31 us-gaap: Other income (expense), net xbrli:monetaryItemType duration credit us-gaap:OtherNonoperatingIncomeExpense
32 us-gaap: Income before income tax expense xbrli:monetaryItemType duration credit us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
33 us-gaap: Income tax expense xbrli:monetaryItemType duration debit us-gaap:IncomeTaxExpenseBenefit
34 us-gaap: Net income xbrli:monetaryItemType duration credit us-gaap:ProfitLoss
35 us-gaap: Net income attributable to noncontrolling interest, net of tax xbrli:monetaryItemType duration debit us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
36 us-gaap: Net income attributable to Biogen Idec Inc. xbrli:monetaryItemType duration credit us-gaap:NetIncomeLoss
37 us-gaap: Basic earnings per share attributable to Biogen Idec Inc. us-types:perShareItemType duration us-gaap:EarningsPerShareBasic
38 us-gaap: Diluted earnings per share attributable to Biogen Idec Inc. us-types:perShareItemType duration us-gaap:EarningsPerShareDiluted
39 us-gaap: Weighted-average shares used in calculating: xbrli:stringItemType duration us-gaap:SharesUsedInComputationOfEarningsLossPerShareAbstract
40 us-gaap: Basic earnings per share attributable to Biogen Idec Inc. xbrli:sharesItemType duration us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
41 us-gaap: Diluted earnings per share attributable to Biogen Idec Inc. xbrli:sharesItemType duration us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
* Network: (02 - Statement - Consolidated Balance Sheets (Unaudited))
42 us-gaap: Balance Sheets [Abstract] xbrli:stringItemType duration us-gaap:StatementOfFinancialPositionAbstract
43 us-gaap: Statement [Table] xbrli:stringItemType duration us-gaap:StatementTable
44 us-gaap: Statement [Line Items] xbrli:stringItemType duration us-gaap:StatementLineItems
45 us-gaap: ASSETS xbrli:stringItemType duration us-gaap:AssetsAbstract
46 us-gaap: Current assets: xbrli:stringItemType duration us-gaap:AssetsCurrentAbstract
47 us-gaap: Cash and cash equivalents xbrli:monetaryItemType instant debit us-gaap:CashAndCashEquivalentsAtCarryingValue
48 us-gaap: Marketable securities xbrli:monetaryItemType instant debit us-gaap:MarketableSecuritiesCurrent
49 biib: Collateral received for loaned securities xbrli:monetaryItemType instant debit biib:CollateralReceivedForLoanedSecurities
50 us-gaap: Accounts receivable, net xbrli:monetaryItemType instant debit us-gaap:AccountsReceivableNetCurrent
51 biib: Due from unconsolidated joint business xbrli:monetaryItemType instant debit biib:DueFromUnconsolidatedJointBusiness
52 biib: Loaned securities xbrli:monetaryItemType instant debit biib:LoanedSecurities
53 us-gaap: Inventory xbrli:monetaryItemType instant debit us-gaap:InventoryNet
54 us-gaap: Other current assets xbrli:monetaryItemType instant debit us-gaap:OtherAssetsCurrent
55 us-gaap: Total current assets xbrli:monetaryItemType instant debit us-gaap:AssetsCurrent
56 us-gaap: Marketable securities xbrli:monetaryItemType instant debit us-gaap:MarketableSecuritiesNoncurrent
57 us-gaap: Property, plant and equipment, net xbrli:monetaryItemType instant debit us-gaap:PropertyPlantAndEquipmentNet
58 us-gaap: Intangible assets, net xbrli:monetaryItemType instant debit us-gaap:IntangibleAssetsNetExcludingGoodwill
59 us-gaap: Goodwill xbrli:monetaryItemType instant debit us-gaap:Goodwill
60 us-gaap: Investments and other assets xbrli:monetaryItemType instant debit us-gaap:OtherAssetsNoncurrent
61 us-gaap: Total assets xbrli:monetaryItemType instant debit us-gaap:Assets
62 us-gaap: LIABILITIES AND EQUITY xbrli:stringItemType duration us-gaap:LiabilitiesAndStockholdersEquityAbstract
63 us-gaap: Current liabilities: xbrli:stringItemType duration us-gaap:LiabilitiesCurrentAbstract
64 biib: Collateral payable on loaned securities xbrli:monetaryItemType instant credit biib:CollateralPayableOnLoanedSecurities
65 us-gaap: Accounts payable xbrli:monetaryItemType instant credit us-gaap:AccountsPayableCurrent
66 us-gaap: Taxes payable xbrli:monetaryItemType instant credit us-gaap:TaxesPayableCurrent
67 us-gaap: Accrued expenses and other xbrli:monetaryItemType instant credit us-gaap:OtherLiabilitiesCurrent
68 us-gaap: Current portion of notes payable and line of credit xbrli:monetaryItemType instant credit us-gaap:NotesPayableCurrent
69 us-gaap: Total current liabilities xbrli:monetaryItemType instant credit us-gaap:LiabilitiesCurrent
70 us-gaap: Notes payable and line of credit xbrli:monetaryItemType instant credit us-gaap:LongTermNotesPayable
71 us-gaap: Long-term deferred tax liability xbrli:monetaryItemType instant credit us-gaap:DeferredTaxLiabilitiesNoncurrent
72 us-gaap: Other long-term liabilities xbrli:monetaryItemType instant credit us-gaap:OtherLiabilitiesNoncurrent
73 us-gaap: Total liabilities xbrli:monetaryItemType instant credit us-gaap:Liabilities
74 us-gaap: Commitments and contingencies xbrli:stringItemType duration us-gaap:CommitmentsAndContingencies2009
75 us-gaap: Equity: xbrli:stringItemType duration us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract
76 us-gaap: Preferred stock, par value $0.001 per share xbrli:monetaryItemType instant credit us-gaap:PreferredStockValue
77 us-gaap: Common stock, par value $0.0005 per share xbrli:monetaryItemType instant credit us-gaap:CommonStockValue
78 us-gaap: Additional paid-in capital xbrli:monetaryItemType instant credit us-gaap:AdditionalPaidInCapital
79 us-gaap: Accumulated other comprehensive income (loss) xbrli:monetaryItemType instant credit us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
80 us-gaap: Retained earnings xbrli:monetaryItemType instant credit us-gaap:RetainedEarningsAccumulatedDeficit
81 us-gaap: Treasury stock, at cost xbrli:monetaryItemType instant debit us-gaap:TreasuryStockValue
82 us-gaap: Total Biogen Idec Inc. shareholders' equity xbrli:monetaryItemType instant credit us-gaap:StockholdersEquity
83 us-gaap: Noncontrolling interest xbrli:monetaryItemType instant credit us-gaap:MinorityInterest
84 us-gaap: Total equity xbrli:monetaryItemType instant credit us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
85 us-gaap: Total liabilities and equity xbrli:monetaryItemType instant credit us-gaap:LiabilitiesAndStockholdersEquity
* Network: (021 - Statement - Consolidated Balance Sheets (Parenthetical) (Unaudited))
86 us-gaap: Balance Sheets [Abstract] xbrli:stringItemType duration us-gaap:StatementOfFinancialPositionAbstract
87 us-gaap: Statement [Table] xbrli:stringItemType duration us-gaap:StatementTable
88 us-gaap: Statement [Line Items] xbrli:stringItemType duration us-gaap:StatementLineItems
89 us-gaap: Preferred stock, par value us-types:perShareItemType instant us-gaap:PreferredStockParOrStatedValuePerShare
90 us-gaap: Common stock, par value us-types:perShareItemType instant us-gaap:CommonStockParOrStatedValuePerShare
* Network: (03 - Statement - Consolidated Statements of Cash Flows (Unaudited))
91 us-gaap: Statements of Cash Flows [Abstract] xbrli:stringItemType duration us-gaap:StatementOfCashFlowsAbstract
92 us-gaap: Statement [Table] xbrli:stringItemType duration us-gaap:StatementTable
93 us-gaap: Statement [Line Items] xbrli:stringItemType duration us-gaap:StatementLineItems
94 us-gaap: Cash flows from operating activities: xbrli:stringItemType duration us-gaap:NetCashProvidedByUsedInOperatingActivitiesAbstract
95 us-gaap: Net income xbrli:monetaryItemType duration credit us-gaap:ProfitLoss
96 us-gaap: Adjustments to reconcile net income to net cash flows from operating activities: xbrli:stringItemType duration us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract
97 us-gaap: Depreciation and amortization of property, plant and equipment and intangible assets xbrli:monetaryItemType duration debit us-gaap:DepreciationAndAmortization
98 us-gaap: Acquired in-process research and development xbrli:monetaryItemType duration debit us-gaap:ResearchAndDevelopmentInProcess
99 us-gaap: Share-based compensation xbrli:monetaryItemType duration debit us-gaap:ShareBasedCompensation
100 us-gaap: Non-cash interest (income) expense and foreign exchange remeasurement loss (gain), net xbrli:monetaryItemType duration debit us-gaap:OtherNoncashExpense
101 us-gaap: Deferred income taxes xbrli:monetaryItemType duration debit us-gaap:DeferredIncomeTaxExpenseBenefit
102 us-gaap: Realized loss (gain) on sale of marketable securities and strategic investments xbrli:monetaryItemType duration credit us-gaap:GainLossOnInvestments
103 us-gaap: Write-down of inventory to net realizable value xbrli:monetaryItemType duration debit us-gaap:InventoryWriteDown
104 us-gaap: Impairment of marketable securities, investments and other assets xbrli:monetaryItemType duration debit us-gaap:ImpairmentOfInvestments
105 us-gaap: Excess tax benefit from stock options xbrli:monetaryItemType duration credit us-gaap:ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
106 us-gaap: Changes in operating assets and liabilities, net: xbrli:stringItemType duration us-gaap:IncreaseDecreaseInOperatingCapitalAbstract
107 us-gaap: Accounts receivable xbrli:monetaryItemType duration credit us-gaap:IncreaseDecreaseInAccountsReceivable
108 biib: Due from unconsolidated joint business xbrli:monetaryItemType duration credit biib:IncreaseDecreaseInDueFromUnconsolidatedJointBusiness
109 us-gaap: Inventory xbrli:monetaryItemType duration credit us-gaap:IncreaseDecreaseInInventories
110 us-gaap: Other assets xbrli:monetaryItemType duration credit us-gaap:IncreaseDecreaseInOtherOperatingAssets
111 us-gaap: Accrued expenses and other current liabilities xbrli:monetaryItemType duration debit us-gaap:IncreaseDecreaseInAccruedLiabilities
112 us-gaap: Other liabilities and taxes payable xbrli:monetaryItemType duration debit us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
113 us-gaap: Net cash flows provided by operating activities xbrli:monetaryItemType duration us-gaap:NetCashProvidedByUsedInOperatingActivities
114 us-gaap: Cash flows from investing activities: xbrli:stringItemType duration us-gaap:NetCashProvidedByUsedInInvestingActivitiesAbstract
115 us-gaap: Purchases of marketable securities xbrli:monetaryItemType duration credit us-gaap:PaymentsToAcquireMarketableSecurities
116 us-gaap: Proceeds from sales and maturities of marketable securities xbrli:monetaryItemType duration debit us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
117 biib: Collateral received under securities leading xbrli:monetaryItemType duration debit biib:CollateralReceivedUnderSecuritiesLending
118 us-gaap: Acquisitions, net of cash acquired xbrli:monetaryItemType duration credit us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
119 us-gaap: Purchases of property, plant and equipment xbrli:monetaryItemType duration credit us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
120 us-gaap: Proceeds from the sale of property, plant and equipment xbrli:monetaryItemType duration debit us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
121 us-gaap: Purchases of other investments xbrli:monetaryItemType duration credit us-gaap:PaymentsToAcquireOtherInvestments
122 biib: Proceeds from the sale of a strategic equity investment xbrli:monetaryItemType duration debit biib:ProceedsFromSaleOfStrategicEquityInvestment
123 us-gaap: Net cash flows (used in) provided by investing activities xbrli:monetaryItemType duration debit us-gaap:NetCashProvidedByUsedInInvestingActivities
124 us-gaap: Cash flows from financing activities: xbrli:stringItemType duration us-gaap:NetCashProvidedByUsedInFinancingActivitiesAbstract
125 us-gaap: Purchase of treasury stock xbrli:monetaryItemType duration credit us-gaap:PaymentsForRepurchaseOfCommonStock
126 us-gaap: Proceeds from issuance of stock for share-based compensation arrangements xbrli:monetaryItemType duration debit us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
127 us-gaap: Change in cash overdraft xbrli:monetaryItemType duration debit us-gaap:ProceedsFromRepaymentsOfBankOverdrafts
128 us-gaap: Excess tax benefit from stock options xbrli:monetaryItemType duration debit us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
129 us-gaap: Proceeds from borrowings xbrli:monetaryItemType duration debit us-gaap:ProceedsFromShortTermDebt
130 us-gaap: Repayment of borrowings xbrli:monetaryItemType duration credit us-gaap:RepaymentsOfShortTermDebt
131 biib: Obligation under securities lending xbrli:monetaryItemType duration credit biib:ObligationUnderSecuritiesLending
132 us-gaap: Net cash flows used in financing activities xbrli:monetaryItemType duration debit us-gaap:NetCashProvidedByUsedInFinancingActivities
133 us-gaap: Net (decrease) increase in cash and cash equivalents xbrli:monetaryItemType duration us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease
134 us-gaap: Effect of exchange rate changes on cash and cash equivalents xbrli:monetaryItemType duration debit us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents
135 us-gaap: Cash and cash equivalents, beginning of the period xbrli:monetaryItemType instant debit us-gaap:CashAndCashEquivalentsAtCarryingValue
136 us-gaap: Cash and cash equivalents, end of the period xbrli:monetaryItemType instant debit us-gaap:CashAndCashEquivalentsAtCarryingValue
* Network: (0601 - Disclosure - Business Overview)
137 us-gaap: Business Overview [Abstract] xbrli:stringItemType duration us-gaap:GeneralPoliciesAbstract
138 us-gaap: Business Overview us-types:textBlockItemType duration us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
* Network: (0602 - Disclosure - Inventory)
139 us-gaap: Inventory [Abstract] xbrli:stringItemType duration us-gaap:InventoryNetAbstract
140 us-gaap: Inventory us-types:textBlockItemType duration us-gaap:InventoryDisclosureTextBlock
* Network: (0603 - Disclosure - Revenue Recognition)
141 biib: Revenue Recognition [Abstract] xbrli:stringItemType duration biib:RevenueRecognitionAbstract
142 biib: Revenue Recognition us-types:textBlockItemType duration biib:RevenueRecognitionTextBlock
* Network: (0604 - Disclosure - Intangible Assets and Goodwill)
143 biib: Intangible Assets and Goodwill [Abstract] xbrli:stringItemType duration biib:IntangibleAssetsAndGoodwillAbstract
144 us-gaap: Intangible Assets and Goodwill us-types:textBlockItemType duration us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
* Network: (0605 - Disclosure - Fair Value Measurements)
145 biib: Fair Value Measurements [Abstract] xbrli:stringItemType duration biib:FairValueMeasurementsAbstract
146 us-gaap: Fair Value Measurements us-types:textBlockItemType duration us-gaap:FairValueDisclosuresTextBlock
* Network: (0606 - Disclosure - Financial Instruments)
147 biib: Financial Instruments [Abstract] xbrli:stringItemType duration biib:FinancialInstrumentsAbstract
148 biib: Financial Instruments us-types:textBlockItemType duration biib:FinancialInstrumentsTextBlock
* Network: (0607 - Disclosure - Derivative Instruments)
149 us-gaap: Derivative Instruments [Abstract] xbrli:stringItemType duration us-gaap:DerivativeInstrumentsAndHedgesAbstract
150 biib: Derivative Instruments us-types:textBlockItemType duration biib:DerivativeInstrumentsTextBlock
* Network: (0608 - Disclosure - Property Plant and Equipment)
151 us-gaap: Property, Plant and Equipment [Abstract] xbrli:stringItemType duration us-gaap:PropertyPlantAndEquipmentNetAbstract
152 biib: Property, Plant and Equipment us-types:textBlockItemType duration biib:PropertyPlantAndEquipmentsTextBlock
* Network: (0609 - Disclosure - Equity)
153 us-gaap: Equity [Abstract] xbrli:stringItemType duration us-gaap:StockholdersEquityNoteAbstract
154 biib: Equity us-types:textBlockItemType duration biib:EquityNoteDisclosureTextBlock
* Network: (0610 - Disclosure - Earnings per Share)
155 us-gaap: Earnings per Share [Abstract] xbrli:stringItemType duration us-gaap:EarningsPerShareAbstract
156 us-gaap: Earnings per Share us-types:textBlockItemType duration us-gaap:EarningsPerShareTextBlock
* Network: (0611 - Disclosure - Share Based Payments)
157 us-gaap: Share-Based Payments [Abstract] xbrli:stringItemType duration us-gaap:ShareBasedCompensationAbstract
158 us-gaap: Share-Based Payments us-types:textBlockItemType duration us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
* Network: (0612 - Disclosure - Income Taxes)
159 us-gaap: Income Taxes [Abstract] xbrli:stringItemType duration us-gaap:IncomeTaxExpenseBenefitAbstract
160 us-gaap: Income Taxes us-types:textBlockItemType duration us-gaap:IncomeTaxDisclosureTextBlock
* Network: (0613 - Disclosure - Other Income (Expense), Net)
161 us-gaap: Other Income (Expense), Net [Abstract] xbrli:stringItemType duration us-gaap:NonoperatingIncomeExpenseAbstract
162 us-gaap: Other Income (Expense), Net us-types:textBlockItemType duration us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock
* Network: (0614 - Disclosure - Collaborations)
163 biib: Collaborations [Abstract] xbrli:stringItemType duration biib:CollaborationsAbstract
164 us-gaap: Collaborations us-types:textBlockItemType duration us-gaap:CollaborativeArrangementDisclosureTextBlock
* Network: (0615 - Disclosure - Litigation)
165 biib: Litigation [Abstract] xbrli:stringItemType duration biib:LitigationAbstract
166 biib: Litigation us-types:textBlockItemType duration biib:LitigationTextBlock
* Network: (0616 - Disclosure - Segment Information)
167 biib: Segment Information [Abstract] xbrli:stringItemType duration biib:SegmentInformationAbstract
168 us-gaap: Segment Information us-types:textBlockItemType duration us-gaap:SegmentReportingDisclosureTextBlock
* Network: (0617 - Disclosure - New Accounting Pronouncements)
169 us-gaap: New Accounting Pronouncements [Abstract] xbrli:stringItemType duration us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract
170 us-gaap: New Accounting Pronouncements us-types:textBlockItemType duration us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock